Menu

Latest Pharma Insights



Finance Watch: SPACs Attempt A Comeback Ahead Of Full IPO Recovery
Public Company Edition: Several special purpose acquisition corporations have emerged, including various health care- and life science-focused SPACs. Also, Alvotech...
Scrip - June 20, 2024
Gilead’s Twice-Annual Sunlenca Posts Zero Infection Rate In PrEP Trial
Lenacapavir is halfway to the pivotal data needed to file for twice-annual administration in PrEP, after demonstrating superiority against both...
Scrip - June 20, 2024
Anti-TROP2 ADCs Lung Cancer Futures Likely Lie In Earlier-Stage Disease
The discussant at ASCO’s NSCLC session said the field would need to “manage expectations” as the drugs do not appear...
Scrip - June 20, 2024
Outdated Technology Keeping Surgeons From Operating At Their Best: Medtronic Report
Cutting edge technology could significantly enhance operating room efficiency, according to a new report from Medtronic. The problem, however, is...
Medtech Insight - June 20, 2024
Jazz’s Suvecaltamide Fails In Tremor Trial, But Parkinson’s Study Continues
A Phase IIb trial evaluating suvecaltamide failed to show a statistically significant benefit versus placebo on an assessment scale for...
Scrip - June 20, 2024
CV Sciences Makes Move For Increased Softgel Capacity, Captek Launches Gummy Production
CV Sciences closes purchase of Elevated Softgels, a manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry...
HBW Insight - June 20, 2024
340B Drug Diversion: Sanofi Suit Seeks Evidence In Pharmacy Contracts With Hospitals
Drug maker pursuing novel approach to establishing that contract pharmacies are improperly taking ‘title’ to 340B-discounted drugs, leading to diversion...
Pink Sheet - June 20, 2024
‘We Tried It, It Does Not Work’ – The Problems With The EU’s SPC Manufacturing Waiver
While the European supplementary protection certificate manufacturing waiver was once seen as a triumph for the region’s off-patent industry, concerns...
Pink Sheet - June 20, 2024
Anti-Globalism Policy Cannot Stifle International Cooperation, US FDA’s Califf Says
The FDA commissioner said that supply chains will remain interconnected no matter how much nationalism dominates the political landscape, meaning...
Pink Sheet - June 20, 2024
California Court Delivers ‘Win’ For Cosmetics Companies In Prop 65 TiO2 Case
Proposition 65 titanium dioxide lawsuits have been halted by a ruling in California in a First Amendment case, which could...
HBW Insight - June 20, 2024
Biosimilars: US FDA Heralds The End Of Switching Studies For Interchangeability
New guidance suggests that switching studies will no longer be expected as standard to support determinations of biosimilar interchangeability; instead...
Pink Sheet - June 20, 2024
EU Pharma Reform Talks Heat Up As Health Ministers Prepare To Challenge Proposals
In a sign of difficult negotiations to come on the European Commission’s pharma reform package, the presidency of the Council...
Pink Sheet - June 20, 2024
NICE Backs Vertex’s CF Drugs Kaftrio, Symkevi & Orkambi After Initial Rejection
Cystic fibrosis patients in England will be able to access Vertex’s three combination therapies after the company announced an extended...
Pink Sheet - June 20, 2024
Roche Adds Ascidian’s RNA-Writing To Its Neurology Push
A first big pharma partnership for Ascidian, headed up by ex-Biogen research head Michael Ehlers, as the Swiss firm expands...
Scrip - June 20, 2024
FDA Heralds The End Of Switching Studies For Biosimilar Interchangeability
New guidance published by the US FDA suggests that switching studies will no longer be expected as standard to support...
Generics Bulletin - June 20, 2024
Implantica CEO On Potential New Standard Of Care For Treating GERD: RefluxStop
Implantica AG continues European rollout of RefluxStop, a non-active, laparoscopically implanted device for treating gastroesophageal reflux disease (GERD) that offers...
Medtech Insight - June 20, 2024
AbbVie Doubles Down In IBD With Skyrizi Ulcerative Colitis Approval
The US major's blockbuster is already well established as a treatment for Crohn’s disease but the latest thumbs-up from the...
Scrip - June 20, 2024
Executives On The Move: New Hires At Eisai, Connect Biopharma, Actylis And More
Recent moves in the industry include new chief executive officers at Connect Biopharma, Skyhawk Therapeutics and Actylis, plus I-Mab gets new...
Scrip - June 20, 2024
AMR, UTI, Breathomics And 3D Printing Technology Innovators Profiled At BioWales 2024
Breathomics, UTI diagnosis and advanced wound healing innovations were among the center stage technologies at BioWales in London 2024. Hear...
Medtech Insight - June 20, 2024
Who’s Hired? Lupin Appoints CEO To New API CDMO Subsidiary
Lupin has selected a CEO to lead its fresh API CDMO business venture, while the UK’s off-patent group BGMA has...
Generics Bulletin - June 20, 2024
Teva Pulls Out Its Digital Inhaler GoResp From UK Market
Commercial reasons led Teva to withdraw its innovative GoResp Digihaler from the UK market, asking healthcare professionals to stop supplying...
Generics Bulletin - June 20, 2024
Rosemont Takes First Steps Outside UK With Acquisition In Greece
Having earlier this year outlined plans for international expansion, liquids specialist Rosemont has made its first venture outside the UK...
Generics Bulletin - June 20, 2024
Europe Must Not Squander Potential Of Reformulation
At a panel on value added medicines at Medicines for Europe’s 30th annual conference in Dublin last week, Pharmanovia CEO...
Generics Bulletin - June 20, 2024
Parexel On Reimbursement Support, Federated Data Sharing, Diversity Through Communities
Parexel’s chief strategy officer, clinical EVP and India head share thoughts on a winner’s mindset for artificial intelligence, benefits of...
Scrip - June 20, 2024
UK Medical Device Firm Owen Mumford Launches Pelvic Health Consumer Brand
UK medical devices manufacturer Owen Mumford moves into consumer health with umbrella brand Clariti and OTC relaunch of at-home vaginismus...
HBW Insight - June 20, 2024
€80m Cash Boost Helps iOnctura Accelerate Eye Cancer Candidate
The proceeds from the impressive series B financing will help progress roginolisib through Phase II trials.
Scrip - June 20, 2024
ASCO 2024 In Review: A Webinar With Citeline Analysts
Citeline analysts offered deep dives into some of the data presented at the American Society of Clinical Oncology annual meeting...
In Vivo - June 20, 2024

Finance Watch: SPACs Attempt A Comeback Ahead Of Full IPO Recovery
Public Company Edition: Several special purpose acquisition corporations have emerged, including various health care- and life science-focused SPACs. Also, Alvotech...
Scrip - June 20, 2024
Gilead’s Twice-Annual Sunlenca Posts Zero Infection Rate In PrEP Trial
Lenacapavir is halfway to the pivotal data needed to file for twice-annual administration in PrEP, after demonstrating superiority against both...
Scrip - June 20, 2024
Anti-TROP2 ADCs Lung Cancer Futures Likely Lie In Earlier-Stage Disease
The discussant at ASCO’s NSCLC session said the field would need to “manage expectations” as the drugs do not appear...
Scrip - June 20, 2024
Jazz’s Suvecaltamide Fails In Tremor Trial, But Parkinson’s Study Continues
A Phase IIb trial evaluating suvecaltamide failed to show a statistically significant benefit versus placebo on an assessment scale for...
Scrip - June 20, 2024
Roche Adds Ascidian’s RNA-Writing To Its Neurology Push
A first big pharma partnership for Ascidian, headed up by ex-Biogen research head Michael Ehlers, as the Swiss firm expands...
Scrip - June 20, 2024
AbbVie Doubles Down In IBD With Skyrizi Ulcerative Colitis Approval
The US major's blockbuster is already well established as a treatment for Crohn’s disease but the latest thumbs-up from the...
Scrip - June 20, 2024
Executives On The Move: New Hires At Eisai, Connect Biopharma, Actylis And More
Recent moves in the industry include new chief executive officers at Connect Biopharma, Skyhawk Therapeutics and Actylis, plus I-Mab gets new...
Scrip - June 20, 2024
Parexel On Reimbursement Support, Federated Data Sharing, Diversity Through Communities
Parexel’s chief strategy officer, clinical EVP and India head share thoughts on a winner’s mindset for artificial intelligence, benefits of...
Scrip - June 20, 2024
€80m Cash Boost Helps iOnctura Accelerate Eye Cancer Candidate
The proceeds from the impressive series B financing will help progress roginolisib through Phase II trials.
Scrip - June 20, 2024

340B Drug Diversion: Sanofi Suit Seeks Evidence In Pharmacy Contracts With Hospitals
Drug maker pursuing novel approach to establishing that contract pharmacies are improperly taking ‘title’ to 340B-discounted drugs, leading to diversion...
Pink Sheet - June 20, 2024
‘We Tried It, It Does Not Work’ – The Problems With The EU’s SPC Manufacturing Waiver
While the European supplementary protection certificate manufacturing waiver was once seen as a triumph for the region’s off-patent industry, concerns...
Pink Sheet - June 20, 2024
Anti-Globalism Policy Cannot Stifle International Cooperation, US FDA’s Califf Says
The FDA commissioner said that supply chains will remain interconnected no matter how much nationalism dominates the political landscape, meaning...
Pink Sheet - June 20, 2024
Biosimilars: US FDA Heralds The End Of Switching Studies For Interchangeability
New guidance suggests that switching studies will no longer be expected as standard to support determinations of biosimilar interchangeability; instead...
Pink Sheet - June 20, 2024
EU Pharma Reform Talks Heat Up As Health Ministers Prepare To Challenge Proposals
In a sign of difficult negotiations to come on the European Commission’s pharma reform package, the presidency of the Council...
Pink Sheet - June 20, 2024
NICE Backs Vertex’s CF Drugs Kaftrio, Symkevi & Orkambi After Initial Rejection
Cystic fibrosis patients in England will be able to access Vertex’s three combination therapies after the company announced an extended...
Pink Sheet - June 20, 2024

Outdated Technology Keeping Surgeons From Operating At Their Best: Medtronic Report
Cutting edge technology could significantly enhance operating room efficiency, according to a new report from Medtronic. The problem, however, is...
Medtech Insight - June 20, 2024
Implantica CEO On Potential New Standard Of Care For Treating GERD: RefluxStop
Implantica AG continues European rollout of RefluxStop, a non-active, laparoscopically implanted device for treating gastroesophageal reflux disease (GERD) that offers...
Medtech Insight - June 20, 2024
AMR, UTI, Breathomics And 3D Printing Technology Innovators Profiled At BioWales 2024
Breathomics, UTI diagnosis and advanced wound healing innovations were among the center stage technologies at BioWales in London 2024. Hear...
Medtech Insight - June 20, 2024

CV Sciences Makes Move For Increased Softgel Capacity, Captek Launches Gummy Production
CV Sciences closes purchase of Elevated Softgels, a manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry...
HBW Insight - June 20, 2024
California Court Delivers ‘Win’ For Cosmetics Companies In Prop 65 TiO2 Case
Proposition 65 titanium dioxide lawsuits have been halted by a ruling in California in a First Amendment case, which could...
HBW Insight - June 20, 2024
UK Medical Device Firm Owen Mumford Launches Pelvic Health Consumer Brand
UK medical devices manufacturer Owen Mumford moves into consumer health with umbrella brand Clariti and OTC relaunch of at-home vaginismus...
HBW Insight - June 20, 2024

FDA Heralds The End Of Switching Studies For Biosimilar Interchangeability
New guidance published by the US FDA suggests that switching studies will no longer be expected as standard to support...
Generics Bulletin - June 20, 2024
Who’s Hired? Lupin Appoints CEO To New API CDMO Subsidiary
Lupin has selected a CEO to lead its fresh API CDMO business venture, while the UK’s off-patent group BGMA has...
Generics Bulletin - June 20, 2024
Teva Pulls Out Its Digital Inhaler GoResp From UK Market
Commercial reasons led Teva to withdraw its innovative GoResp Digihaler from the UK market, asking healthcare professionals to stop supplying...
Generics Bulletin - June 20, 2024
Rosemont Takes First Steps Outside UK With Acquisition In Greece
Having earlier this year outlined plans for international expansion, liquids specialist Rosemont has made its first venture outside the UK...
Generics Bulletin - June 20, 2024
Europe Must Not Squander Potential Of Reformulation
At a panel on value added medicines at Medicines for Europe’s 30th annual conference in Dublin last week, Pharmanovia CEO...
Generics Bulletin - June 20, 2024

ASCO 2024 In Review: A Webinar With Citeline Analysts
Citeline analysts offered deep dives into some of the data presented at the American Society of Clinical Oncology annual meeting...
In Vivo - June 20, 2024